Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Amgen, BMS and Eli Lilly support industry code

Amgen, BMS and Eli Lilly support industry code

11th July 2008

Amgen, Bristol-Myers Squibb (BMS) and Eli Lilly have expressed their commitment to an enhanced code on interactions with healthcare professionals.

The firms said they would comply with the new code from Pharmaceuticals Research and Manufacturers of America (PhRMA).

Amgen commented that its voluntary support is the latest part of its ongoing Clearly Amgen initiative.

BMS said the code supports the tenet that proper interactions between healthcare professionals and pharmaceutical firms plays a key role in improving healthcare.

Lilly said it will implement its own external verification to guarantee its own policies and processes comply with the code.

Earlier this week, PhRMA unveiled an update to its code on interactions between biotechnology and pharmaceutical firms and healthcare professionals.

The code offers guidance on the use of promotional materials, grants and consulting arrangements, ongoing medical arrangements, meals and entertainment, sales and marketing training and clinical practice guidelines.

It will be implemented in January 2009.

Robert Brown, chief marketing and operations officer for US operations at Lilly, said: “We believe that the meaningful Code revisions that have been adopted will address the concerns of our various stakeholders and strengthen the public trust in our industry.”

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.